New‐onset autoimmune phenomena post‐COVID‐19 vaccination

Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …

[HTML][HTML] Therapeutic targeting of NF-κB in acute lung injury: A double-edged sword

MW Millar, F Fazal, A Rahman - Cells, 2022 - mdpi.com
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a devastating disease
that can be caused by a variety of conditions including pneumonia, sepsis, trauma, and most …

[HTML][HTML] Longitudinal cytokine profile in patients with mild to critical COVID-19

L Ling, Z Chen, G Lui, CK Wong, WT Wong… - Frontiers in …, 2021 - frontiersin.org
The cytokine release syndrome has been proposed as the driver of inflammation in
coronavirus disease 2019 (COVID-19). However, studies on longitudinal cytokine profiles in …

[HTML][HTML] The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Q Ning, D Wu, X Wang, D Xi, T Chen, G Chen… - … and Targeted Therapy, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

[HTML][HTML] Prospective roles of tumor necrosis factor-alpha (TNF-α) in COVID-19: prognosis, therapeutic and management

Z Mohd Zawawi, J Kalyanasundram… - International journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) became a worldwide concern at the beginning of
2020 and has affected millions. Several previous studies revealed the impact of the …

[HTML][HTML] Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

M Torres, G Casado, L Vigón, S Rodríguez-Mora… - Biomedicine & …, 2022 - Elsevier
Main cause of severe illness and death in COVID-19 patients appears to be an excessive
but ineffectual inflammatory immune response that may cause severe acute respiratory …

[HTML][HTML] Interleukin-18 is a potential biomarker to discriminate active adult-onset still's disease from COVID-19

PK Chen, JL Lan, PH Huang, JL Hsu… - Frontiers in …, 2021 - frontiersin.org
Background Hyperinflammation with dysregulated production of galectins and cytokines
may develop in COVID-19 or adult-onset Still's disease (AOSD). Given the similar clinical …

[HTML][HTML] Alveolar type II cells and pulmonary surfactant in COVID-19 era

A Calkovska, M Kolomaznik… - Physiological Research, 2021 - ncbi.nlm.nih.gov
In this review, we discuss the role of pulmonary surfactant in the host defense against
respiratory pathogens, including novel coronavirus SARS-CoV-2. In the lower respiratory …

[HTML][HTML] Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

[HTML][HTML] Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination

DL Ramatillah, SH Gan, I Pratiwy, SA Syed Sulaiman… - PloS One, 2022 - journals.plos.org
Background and aim Coronavirus Disease 2019 (COVID-19) has become a worldwide
pandemic and is a threat to global health. Patients who experienced cytokine storms tend to …